TimeScale Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$101K Hold
227
0.02% 154
2023
Q1
$104K Buy
227
+1
+0.4% +$476 0.02% 146
2022
Q4
$103K Buy
226
+1
+0.4% +$508 0.03% 112
2022
Q3
$103K Hold
225
0.03% 111
2022
Q2
$109K Hold
225
0.03% 109
2022
Q1
$110K Buy
225
+1
+0.4% +$457 0.03% 120
2021
Q4
$104K Buy
224
+49
+28% +$20.6K 0.02% 128
2021
Q3
$66K Hold
175
0.02% 154
2021
Q2
$67K Hold
175
0.02% 155
2021
Q1
$63K Buy
175
+1
+0.6% +$322 0.02% 163
2020
Q4
$56K Hold
174
0.02% 152
2020
Q3
$47K Buy
174
+1
+0.6% +$269 0.01% 157
2020
Q2
$46K Hold
173
0.01% 156
2020
Q1
$39K Hold
173
0.01% 151
2019
Q4
$52K Hold
173
0.02% 170
2019
Q3
$42K Hold
173
0.01% 190
2019
Q2
$49K Buy
+173
New +$47.3K 0.02% 184

Other funds holding ELV

TimeScale Financial's ELV Position: Q2 2023 in Review

TimeScale Financial held its Elevance Health (ELV) position steady in Q2 2023 at 227 shares worth $101K. The position accounts for 0.02% of the portfolio, ranked #154.

TimeScale Financial first reported a position in ELV in Q2 2019 and has held it in 17 quarters since. The position peaked at $110K in Q1 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • TimeScale Financial held 227 shares of Elevance Health worth $101K as of Q2 2023.
  • TimeScale Financial left its Elevance Health share count unchanged in Q2 2023.
  • Elevance Health made up 0.02% of TimeScale Financial's portfolio in Q2 2023, its #154 holding.
  • TimeScale Financial first reported a position in Elevance Health in Q2 2019 and has held it in 17 quarters since.
  • TimeScale Financial's Elevance Health position peaked at $110K in Q1 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.